Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
|Active Ingredient:||Povidone-iodine 10%w/w equivalent to iodine 1%w/w|
|Dosage Form:||Topical ointment|
|New Zealand Sponsor:||Sanofi-Aventis New Zealand Limited|
|Manufacturer:||Mayne Pharma International Pty Limited, Adelaide, Australia|
Dated this 28th day of July 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).